Olink Holding AB (OLK)
23.95
-0.06
(-0.25%)
USD |
NASDAQ |
May 16, 16:00
23.94
-0.01
(-0.04%)
After-Hours: 20:00
Olink Total Liabilities (Quarterly): 81.33M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 81.33M |
| December 31, 2023 | 99.55M |
| September 30, 2023 | 80.72M |
| June 30, 2023 | 60.00M |
| March 31, 2023 | 61.92M |
| December 31, 2022 | 65.60M |
| September 30, 2022 | 59.26M |
| Date | Value |
|---|---|
| June 30, 2022 | 62.44M |
| March 31, 2022 | 61.76M |
| December 31, 2021 | 64.10M |
| September 30, 2021 | 57.43M |
| June 30, 2021 | 57.99M |
| March 31, 2021 | 60.60M |
| December 31, 2020 | 125.62M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
57.43M
Minimum
Sep 2021
125.62M
Maximum
Dec 2020
71.31M
Average
62.18M
Median
Total Liabilities (Quarterly) Benchmarks
| Thermo Fisher Scientific Inc | 51.47B |
| Abliva AB | 1.667M |
| Karolinska Development AB | 1.233M |
| Calliditas Therapeutics AB | 151.43M |
| Oncopeptides AB | 14.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 542.96M |
| Shareholders Equity (Quarterly) | 461.63M |
| Current Ratio | 5.598 |